Synthomer Share Discussion Threads

[james dean] 11/1/2021 12:59

Nice - thanks.

[philanderer] 11/1/2021 10:14

JPMORGAN RAISES SYNTHOMER PRICE TARGET TO 500 (450) PENCE - 'OVERWEIGHT'

[philanderer] 16/12/2020 13:43

But looking very good today.

[philanderer] 11/12/2020 12:54

Getting tw@tted today.

[philanderer] 07/12/2020 10:15

BOFA RAISES SYNTHOMER PRICE TARGET TO 440 (400) PENCE - 'NEUTRAL'

[james dean] 04/12/2020 13:59

After the last couple of days I thought it had lost its spirit.

Returned today - let the force be with it.

[philanderer] 04/12/2020 12:45

1 million printed so far.

[philanderer] 04/12/2020 11:25

What's happened here today !!

[philanderer] 17/11/2020 10:33

18th November 2020

14:30 to 16:30 GMT

Synthomer plc – update post the Omnova acquisition (virtual event)

(Invitation only - Please RSVP [e-mail] if you would like to participate)

HTTPS://www.synthomer.com/investor-relations/synthomer-plc/investor-home/?region=EUROPE

[witheco] 17/11/2020 06:43

This has been a really good performer on the year (as a substitute for Avon) - and still looks relatively cheap with P/E < 25. Will it be carried over valuation? The rule is buy on value but never sell on value.

[philanderer] 06/11/2020 14:17

400p , who'd have thunk it in april ;-)

[philanderer] 27/10/2020 00:11

Synthomer PLC (LON:SYNT) was upgraded to ‘overweight217; from ‘neutral’; by JP Morgan after analysts looked at the company’s exposure to the gloves market.

The polymer, sealant and chemicals specialist sells nitrile latex for nitrile gloves, a business which accounted for around 20% of 2019 group earnings.

The main manufacturer in the sector, Top Glove, recently indicated that their lead time for nitrile gloves has extended significantly to 660 days compared to the average pre-pandemic lead time of 30-40 days.

The US investment bank said gloves demand will moderate as COVID-19 vaccines become widely available, which may not be until the second half of 2021 or 2022, though it is also possible that the greater focus on hygiene might result in structurally higher gloves demand in the future.

“We believe that both the magnitude and the duration of this upside is likely to be better than the market assumes,” analysts noted, while raising the target price to 450p.

“There is a potential of further significant upside as we have significantly discounted the potential tailwind that we calculate from the substantial step-up seen in nitrile prices/spreads due to tight supply.”


proactiveinvestors.co.uk/

[philanderer] 26/10/2020 14:15

Indeed it has ;-)

Synthomer, up 2.5%. JPMorgan raised the speciality chemicals firm to Overweight from Neutral...tp 450p

[deadly] 26/10/2020 09:15

up 5% so far today. Tipped somewhere?

[philanderer] 21/10/2020 09:35

xd tomorrow morning for the 3p dividend

[james dean] 21/10/2020 09:30

philanderer

Thanks.

[philanderer] 21/10/2020 09:17

JEFFERIES RAISES SYNTHOMER PRICE TARGET TO 440 (370) PENCE - 'BUY'

MORGAN STANLEY RAISES SYNTHOMER TARGET TO 380 (350) PENCE - 'EQUAL-WEIGHT'

[philanderer] 19/10/2020 09:08

BERENBERG RAISES SYNTHOMER PRICE TARGET TO 430 (370) PENCE - 'BUY'

[philanderer] 14/10/2020 17:29

As of last night..

7th oct UBS neutral tp 325p
23rd sept Credit Suisse outperform tp 380p
18th sept HSBC buy tp 400p
17th aug Berenberg buy tp 370p
12th aug Barclays overweight tp 330p

6th aug ++++ trading/interims +++++

[sphere25] 14/10/2020 13:34

Very impressive performance:

EBITDA: £232M
2.0x net debt to EBITDA by December 2020.

Market cap @ 394: £1,670M

Those multiples don't look excessive. I think this could end up significantly higher from these levels.

Further upgrades to come? Looks a buy the dip play

DBAM DYOR

[james dean] 14/10/2020 08:04

Pleasing update.

[deadly] 14/10/2020 07:55

Wow, that is a great update, and flying well below the radar.

[robow] 14/10/2020 07:23

FY2020 EBITDA guidance raised 10%, interim dividend reinstated and pro forma leverage expected to reduce to circa 2.0x EBITDA by end of 2020

[philanderer] 13/10/2020 13:20

Two days in a row !

[philanderer] 07/10/2020 10:37

UBS RAISES SYNTHOMER PRICE TARGET TO 325 (305) PENCE - 'NEUTRAL'